Please email us at Sales@AmericanPharmaWholesale.com with our item No, NDC#,UPC#or best is product link. We are located in Oceanside, California. Search over 100,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name.
Menu

RX ITEM-AKYNZEO 300-0.5MG CAP 1 by Helsinn Therapeutics

Item No.:RX69639-0102-01  Generic Name:<br>FOSNETUPITANT/PALONOSETRON<br> Description:<br>AKYNZEO SPD, 235-0.25MG, (1 MG), POWDER VIAL, 1X1 EA<br> Alt Item #: <br>5450424<br> NDC:<br>69639-0102-01<br> Generic Name:
FOSNETUPITANT/PALONOSETRON

 Description:
AKYNZEO SPD, 235-0.25MG, (1 MG), POWDER VIAL, 1X1 EA
 Alt Item #: 
5450424

 NDC:
69639-0102-01

 UPC:
369639-102012
 Contract:

Contract AliasOnly Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

RX ITEM-AKYNZEO 300-0.5MG CAP 1 by Helsinn Therapeutics

$719.80$679.00

AKYNZEO 300-0.5MG CAP 1 by Helsinn Therapeutics Item No. RX640033 640033 NDC 69639-0101-01 69639-101-01 6963910101 6963910101 UPC 369639-101015 3-69639-10101-5 369639101015
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,can order rx items.

Have a question?

These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 RECENT MAJOR CHANGES Indication and Usage (1) 04/2018 Dosage and Administration, Recommended Dosage (2.1) 04/2018 Dosage and Administration, Preparation (2.2) 04/2018 Dosage and Administration, Incompatibility (2.3) 04/2018 INDICATIONS AND USAGE AKYNZEO capsules is indicated in combination with dexamethasone in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. AKYNZEO for injection is indicated in combination with dexamethasone in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Limitations of Use AKYNZEO for injection has not been studied for the prevention of nausea and vomiting associated with anthracycline plus cyclophosphamide chemotherapy. AKYNZEO is a combination of palonosetron, a serotonin-3 (5-HT3) receptor antagonist, and netupitant or fosnetupitant, substance P/neurokinin-1 (NK-1) receptor antagonists: palonosetron prevents nausea and vomiting during the acute phase and netupitant/fosnetupitant prevents nausea and vomiting during both the acute and delayed phase after cancer chemotherapy. (1) DOSAGE AND ADMINISTRATION One AKYNZEO capsule administered approximately 1 hour prior to the start of chemotherapy, with or without food. (2.1) One vial of AKYNZEO for injection; reconstituted in 50 ml of 5% Dextrose Injection, USP or 0.9% Sodium Chloride Injection, USP and administered as 30-minute infusion starting approximately 30 minutes prior to the start of chemotherapy. (2.1, 2.2, 2.3) DOSAGE FORMS AND STRENGTHS Capsules: 300 mg netupitant/0.5 mg palonosetron For Injection: 235 mg fosnetupitant/0.25 mg palonosetron lyophilized powder in a single-dose vial for reconstitution (3) CONTRAINDICATIONS None (4) WARNINGS AND PRECAUTIONS Hypersensitivity reactions, including anaphylaxis, have been reported in patients receiving palonosetron, one of the components of AKYNZEO, with or without known hypersensitivity to other 5-HT3 receptor antagonists. (5.1) Serotonin syndrome has been reported with 5-HT3 receptor antagonists alone but particularly with concomitant use of serotonergic drugs. If such symptoms occur, discontinue AKYNZEO and initiate supportive treatment. If concomitant use of AKYNZEO with other serotonergic drugs is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome. (5.2,7.3) ADVERSE REACTIONS Most common adverse reactions (?3%) for AKYNZEO capsules are headache, asthenia, dyspepsia, fatigue, constipation and erythema (6.1) The safety profile of AKYNZEO for injection was generally similar to that seen with AKYNZEO capsules. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact HELSINN at 1-844-357-4668 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONS CYP3A4 Substrates: inhibition of CYP3A4 by netupitant can result in increased plasma concentrations of the concomitant drug for 6 days after single dosage administration of AKYNZEO; avoid concomitant CYP3A4 substrates for one week, if feasible. If not avoidable, consider dose reduction of the CYP3A4 substrate (7.1) CYP3A4 Inducers (e.g., rifampin): decreased plasma concentrations of netupitant; avoid use (7.2) USE IN SPECIFIC POPULATIONS Pregnancy: May cause fetal harm (8.1). Hepatic Impairment: Avoid use in patients with severe hepatic impairment (8.6) Renal Impairment: Avoid use in patients with severe renal impairment or end-stage renal disease (8.7) See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 4/2018

Item No.:RX69639-0102-01  Generic Name:<br>FOSNETUPITANT/PALONOSETRON<br> Description:<br>AKYNZEO SPD, 235-0.25MG, (1 MG), POWDER VIAL, 1X1 EA<br> Alt Item #: <br>5450424<br> NDC:<br>69639-0102-01<br>
AKYNZEO SPD 235-0.25MG (1 MG) POWDER VIA
Item No.:RX69639-0102-01 Generic Name:
FOSNETUPITANT/PALONOSETRON
Description:
AKYNZEO SPD, 235-0.25MG, (1 MG), POWDER VIAL, 1X1 EA
Alt Item #:
5450424
NDC:
69639-0102-01

 Generic Name:
FOSNETUPITANT/PALONOSETRON

 Description:
AKYNZEO SPD, 235-0.25MG, (1 MG), POWDER VIAL, 1X1 EA
 Alt Item #: 
5450424

 NDC:
69639-0102-01

 UPC:
369639-102012
 Contract:

Contract Alias
HELSINN THERAPEUTIC
Generic Name: FOSNETUPITANT/PALONOSETRON Description: AKYNZEO SPD, 235-0.25MG, (1 MG), POWDER VIAL, 1X1 EA Alt Item #: 5450424 NDC: 69639-0102-01 UPC: 369639-102012 Contract: Contract Alias

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
American Pharma Wholesale
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.